Inflammatory Bowel Disease Drugs Market Share 2021 Growth Challenges, Opportunities and Future Trends 2027
The global inflammatory bowel disease drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Inflammatory bowel disease (IBD) is an umbrella term that is used to describe disorders involving chronic inflammation of the digestive tract. The major factor driving the growth of the market is the increasing prevalence of IBD across the globe.
According to Frontiers Org,
annual incidences of IBD reached 7.24, 6.82, 10.27, and 13.33 per 100,000,
respectively from 2017 to 2020. Additionally, there are two types of IBD
including Crohn's disease (CD) and Ulcerative Colitis (UC). Moreover, annual
incidences of CD reached 4.48, 5.26, 7.39, and 9.8 per 100,000, respectively, while
that of UC were each 2.76, 1.56, 2.88, and 3.53 per 100,000, respectively.
Hence, the increasing prevalence of IBD is driving the demand for inflammatory
bowel disease drugs which in turn is driving the growth of the market.
To Request a Sample of our Report on Inflammatory Bowel
Disease Drugs Market: https://www.omrglobal.com/request-sample/inflammatory-bowel-disease-drugs-market
Some major players in the market include AbbVie Inc., Amgen
Inc., and Bristol-Myers Squibb Co., among others. The market players are
contributing significantly to the growth of the market by the adoption of
various strategies including mergers & acquisitions, geographical expansion,
partnerships and collaborations, and new product launches, to stay competitive
in the market. For instance, in May 2021, Bristol Myers Squibb announced the
approval of Zeposia (ozanimod) from the US Food and Drug Administration (FDA).
It is used for the treatment of moderate to severely active ulcerative colitis
in adults.
Market Coverage
• The
market number available for – 2020-2027
• Base
year- 2020
• Forecast
period- 2021-2027
Segment Covered-
·
By Type
·
By Drug Class
·
By Distribution Channel
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
AbbVie Inc., Amgen Inc., and Bristol-Myers Squibb Co., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Inflammatory Bowel Disease Drugs Market is Available @ https://www.omrglobal.com/industry-reports/inflammatory-bowel-disease-drugs-market
Global Inflammatory Bowel Disease Drugs Market Report by
Segment
By Type
•
Crohn's Disease
•
Ulcerative Colitis
By Drug Class
•
Aminosalicylates
•
Corticosteroids
•
TNF inhibitors
•
IL inhibitors
•
Anti-integrin
•
JAK inhibitors
•
Others
By Distribution Channel
•
Retail Pharmacy
•
Hospital Pharmacy
•
E-commerce
Global Inflammatory Bowel Disease Drugs Market Report by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment